5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity (2010)

Peer-Reviewed Study · Vincent J, Mignot G, Chalmin F, Ladoire S, Bruchard M, Chevriaux A, et al. · April 15, 2010

Vincent J et al., 2010-04-15: Mouse and in vitro study reporting that 5-fluorouracil and gemcitabine are selectively cytotoxic to myeloid-derived suppressor cells, and that depleting MDSCs improved T-cell-dependent antitumour responses.

the treatment of tumor-bearing mice with 5FU led to a major decrease in the number of MDSC in the spleens and tumor beds of animals

Abstract

Vincent J et al., 2010-04-15: Mouse and in vitro study reporting that 5-fluorouracil and gemcitabine are selectively cytotoxic to myeloid-derived suppressor cells, and that depleting MDSCs improved T-cell-dependent antitumour responses. Species caveat: the quoted finding is in tumour-bearing MICE; human data in the paper are in vitro. Comparator: untreated tumour-bearing animals; 5-FU vs gemcitabine. Funder/COI not in the abstract. This is the paper the claim cites; it shows depletion, not expansion, of MDSCs – the opposite of what the book asserts for 5-FU. Study type: animal.